Showing results (21-30 of 58) with videos related to
Sort By:
Pageof 6
Molecular Cancer Therapeutics|January 17, 2020
Extracellular Vesicle-Mediated In Vitro Transcribed mRNA Delivery for Treatment of HER2+ Breast Cancer Xenografts in Mice by Prodrug CB1954 without General ToxicityAlexis V Forterre, Jing-Hung Wang, Alain Delcayre, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2006
Predicting chemotherapy response to paclitaxel with 18F-Fluoropaclitaxel and PETWei-Ann Hsueh, Amanda L Kesner, Anne Gangloff, et al.Breast Cancer Research : BCR|October 9, 2009
Phase I dose escalation pharmacokinetic assessment of intravenous humanized anti-MUC1 antibody AS1402 in patients with advanced breast cancerMark D Pegram, Virginia F Borges, Nuhad Ibrahim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2006
Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancerJudith Hurley, Philomena Doliny, Isildinha Reis, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2007
Biodistribution and predictive value of 18F-fluorocyclophosphamide in mice bearing human breast cancer xenograftsAmanda L Kesner, Wei-Ann Hsueh, Nwe Linn Htet, et al.Molecular Imaging and Biology|December 20, 2005
Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapyBetty S Pio, Cecilia K Park, Richard Pietras, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2024
Impact of the Breast Cancer Index for Extended Endocrine Decision-Making: First Results of the Prospective BCI Registry StudyTara B Sanft, Jenna Wong, Brandon O'Neal, et al.Ebiomedicine|January 13, 2015
Rapid reduction in breast cancer mortality with inorganic arsenic in drinking waterAllan H Smith, Guillermo Marshall, Yan Yuan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2016
Relationship between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast CancerJosé Baselga, Gail D Lewis Phillips, Sunil Verma, et al.Molecular Cancer Therapeutics|February 28, 2018
Anti-HER2 scFv-Directed Extracellular Vesicle-Mediated mRNA-Based Gene Delivery Inhibits Growth of HER2-Positive Human Breast Tumor Xenografts by Prodrug ActivationJing-Hung Wang, Alexis V Forterre, Jinjing Zhao, et al.Pageof 6